John P. Braselton

948 total citations
17 papers, 766 citations indexed

About

John P. Braselton is a scholar working on Cellular and Molecular Neuroscience, Social Psychology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, John P. Braselton has authored 17 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 5 papers in Social Psychology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in John P. Braselton's work include Neurotransmitter Receptor Influence on Behavior (7 papers), Neuroendocrine regulation and behavior (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). John P. Braselton is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (7 papers), Neuroendocrine regulation and behavior (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). John P. Braselton collaborates with scholars based in United States and Germany. John P. Braselton's co-authors include Jeffrey Sprouse, Linda Reynolds, Anne W. Schmidt, F. David Tingley, Robert S. Mansbach, David W. Schulz, Michael L. Corman, Thomas Seeger, Xing‐Fang Li and A. DUNAISKIS and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biological Psychiatry and Annals of the New York Academy of Sciences.

In The Last Decade

John P. Braselton

17 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John P. Braselton United States 11 353 290 173 162 148 17 766
Lotte de Groote Germany 14 339 1.0× 386 1.3× 100 0.6× 215 1.3× 227 1.5× 18 846
Janice Shaw United States 12 142 0.4× 293 1.0× 149 0.9× 107 0.7× 216 1.5× 15 739
Marı́a Inés Forray Chile 15 268 0.8× 431 1.5× 99 0.6× 218 1.3× 217 1.5× 28 783
Jean-Luc Moreau Switzerland 9 188 0.5× 378 1.3× 49 0.3× 137 0.8× 284 1.9× 10 690
Angelo Blasio United States 16 195 0.6× 403 1.4× 181 1.0× 139 0.9× 227 1.5× 22 938
Pavel Hrdina Canada 9 265 0.8× 255 0.9× 30 0.2× 148 0.9× 174 1.2× 16 739
Teniel S Ramikie United States 12 161 0.5× 525 1.8× 67 0.4× 115 0.7× 129 0.9× 12 958
Philip Gerrard United Kingdom 17 144 0.4× 643 2.2× 106 0.6× 157 1.0× 418 2.8× 19 1.1k
Sandy Ghozland United States 9 284 0.8× 951 3.3× 82 0.5× 169 1.0× 626 4.2× 9 1.3k
P. Mortas Switzerland 9 337 1.0× 391 1.3× 47 0.3× 190 1.2× 155 1.0× 9 676

Countries citing papers authored by John P. Braselton

Since Specialization
Citations

This map shows the geographic impact of John P. Braselton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Braselton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Braselton more than expected).

Fields of papers citing papers by John P. Braselton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Braselton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Braselton. The network helps show where John P. Braselton may publish in the future.

Co-authorship network of co-authors of John P. Braselton

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Braselton. A scholar is included among the top collaborators of John P. Braselton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Braselton. John P. Braselton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Yuhpyng L., John P. Braselton, Randall J. Gallaschun, et al.. (2008). Synthesis and SAR of 2-Aryloxy-4-alkoxy-pyridines as Potent Orally Active Corticotropin-Releasing Factor 1 Receptor Antagonists. Journal of Medicinal Chemistry. 51(5). 1377–1384. 35 indexed citations
2.
Chen, Yuhpyng L., R. Scott Obach, John P. Braselton, et al.. (2008). 2-Aryloxy-4-alkylaminopyridines: Discovery of Novel Corticotropin-Releasing Factor 1 Antagonists. Journal of Medicinal Chemistry. 51(5). 1385–1392. 52 indexed citations
3.
Sprouse, Jeffrey, John P. Braselton, & Linda Reynolds. (2006). Fluoxetine Modulates the Circadian Biological Clock via Phase Advances of Suprachiasmatic Nucleus Neuronal Firing. Biological Psychiatry. 60(8). 896–899. 102 indexed citations
4.
Sprouse, Jeffrey, Linda Reynolds, John P. Braselton, & Anne W. Schmidt. (2004). Serotonin‐induced phase advances of SCN neuronal firing in vitro: A possible role for 5‐HT5A receptors?. Synapse. 54(2). 111–118. 33 indexed citations
5.
Sprouse, Jeffrey, Linda Reynolds, Xing‐Fang Li, John P. Braselton, & Anne W. Schmidt. (2003). 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology. 46(1). 52–62. 115 indexed citations
7.
Sprouse, Jeffrey, John P. Braselton, & Linda Reynolds. (2000). 5-HT1A agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus. Biological Psychiatry. 47(12). 1050–1055. 19 indexed citations
8.
9.
Sprouse, Jeffrey, John P. Braselton, & L S Reynolds. (1998). 5‐HT1A Agonist Activity of Pindolol: Reversal of the Inhibitory Effects on Cell Firing in the Dorsal Raphe Nucleus but not in the Hippocampus by WAY‐100,635. Annals of the New York Academy of Sciences. 861(1). 274–275. 10 indexed citations
10.
Schulz, David W., Robert S. Mansbach, Jeffrey Sprouse, et al.. (1996). CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.. Proceedings of the National Academy of Sciences. 93(19). 10477–10482. 308 indexed citations
11.
VanderMaelen, Cam P. & John P. Braselton. (1992). Effects of the antidepressant compound nefazodone on central monoaminergic neuronal discharge in rats. Drug Development Research. 25(3). 235–247. 4 indexed citations
12.
VanderMaelen, Cam P. & John P. Braselton. (1991). Acute administration of the antidepressant trazodone increases noradrenergic locus coeruleus neuronal firing in rats.. PubMed. 308. 13–20. 7 indexed citations
13.
VanderMaelen, Cam P. & John P. Braselton. (1990). Effects of a potential antipsychotic, BMY 14802, on firing of central serotonergic and noradrenergic neurons in rats. European Journal of Pharmacology. 179(3). 357–366. 25 indexed citations
14.
Hanson, Robert C., et al.. (1986). Cardiovascular and renal effects of buspirone in several animal models. General Pharmacology The Vascular System. 17(3). 267–274. 6 indexed citations
15.
Deitchman, David, et al.. (1980). The ganglion-blocked, angiotensin II-supported rat: A model for demonstrating antihypertensive vasodilator activity. Journal of Pharmacological Methods. 3(4). 311–321. 5 indexed citations
16.
Johnson, P. C., et al.. (1973). Antifertility activity of some .beta.-amino alcohols. Journal of Medicinal Chemistry. 16(6). 736–739. 10 indexed citations
17.
McKinney, Gordon R. & John P. Braselton. (1970). Antiandrogenic and antiuterotropic activities of three synthetic progestagens. Steroids. 15(3). 405–411. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026